Location History:
- New Taipei, TW (2016 - 2017)
- Taipei, TW (2008 - 2019)
Company Filing History:
3 out of 11 
3 out of 3 
2 out of 49 Years Active: 2008-2019
Title: Innovations and Contributions of Inventor Wen-Liang Chang
Introduction
Wen-Liang Chang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medications targeting influenza viruses. With a total of 14 patents to his name, his work has had a considerable impact on medical science.
Latest Patents
One of his latest patents involves the usage of mycophenolate mofetil or its pharmaceutically acceptable salts in preparing drugs to resist influenza viruses. This invention not only addresses the treatment of standard influenza but also focuses on drug-resistant strains. Another notable patent discloses a novel use of a lanostane compound aimed at enhancing nutrient uptake, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Wen-Liang Chang has worked with Sinphar Pharmaceutical Co., Ltd., where he has contributed to various research and development projects. His expertise in the pharmaceutical industry has allowed him to explore new avenues for drug development and treatment methodologies.
Collaborations
Throughout his career, Chang has collaborated with notable colleagues, including Hang-Ching Lin and Chen-Wen Yao. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Wen-Liang Chang's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in medical science. His work continues to influence the development of effective treatments for influenza and other health challenges.